Hyderabad-based Aurobindo Pharma has made a milestone in its biosimilar growth plans, when its subsidiary CuraTeQ Biologics s.r.o. received clearance by the UK's Medicines and Healthcare products Regulatory Agency
Pharmaceuticals Export Promotion Council of India (Pharmexcil) has assigned two honorary advisors to provide assistance to export pharmaceutical producers with regulatory issues surrounding Foreign Trade Policy (FTP) permitting and other matters...
Lupin Limited, a multinational pharmaceutical company based in Mumbai, informed that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) on Prucalopride Tablets 1 mg and 2 mg.
Dr Lal PathLabs has enhanced its genomic capabilities by acquiring Illumina's NovaSeq X Series to the dedicated genomics division Genevolve. This additional technology expands the lab's ability to provide rapid and reliable genomic information for...
The Department of Pharmaceuticals will be supporting the research and innovation in pharma and medical technology, as the department has released an online portal for a scheme of Rs.5,000 crore. India is one of the major pharmaceutical m...
India’s pharmaceutical sector is seeing early benefits, as global drugmakers begin to shift a portion of their outsourcing arrangements from China to Indian firms, following the China+1 strategy. Major Contract Research and Manufacturing...
The Serum Institute of India (SII), the world's leading vaccine manufacturer by volume, launched Cervavac, India’s first indigenously manufactured gender-neutral quadrivalent HPV vaccine...
In a major milestone in equitable cancer treatment, Biocon Biologics partnered with the National Cancer Society of Malaysia (NCSM) to put into action a Patient Assistance Programme (PAP) in order to increase access to affordable, quality...
A major step in the direction of infectious disease research in India, Pune-based National Institute of Virology (NIV), under the Indian Council of Medical Research (ICMR), has found anti-viral drug Favipiravir as a potential candidate against Chandi
In a significant milestone for the evolution of cancer care in India, Glenmark Pharmaceuticals announced the launch of Tevimbra (tislelizumab), an innovative immune-oncology drug of the Central Drugs Standard Control Organization (CDSCO)...
, CDSCO.jpg)
